The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Related Articles
ABBV-400 Shows Early Promise in Pretreated, Metastatic Colorectal Cancer
“It does appear like MET expression could be one of the mechanisms wherein you could differentiate between responders and non-responders,” Kanwal P.S. Raghav, MBBS, MD,…
Zongertinib Demonstrates Clinically Meaningful Efficacy in HER2-Mutated NSCLC
Zongertinib demonstrated clinically meaningful efficacy in previously treated HER2-mutated non–small cell lung cancer.
Breakthroughs, Personalization, and the Future of Lymphoma Care
Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies are offering hope for…
Welcome! You are invited to join a webinar: Virtual Tumor Board: GI Malignancy and Inflammatory Bowel Disease . After registering, you will receive a confirmation email about joining the webinar.
Welcome! You are invited to join a webinar: Virtual Tumor Board: GI Malignancy and Inflammatory Bowel Disease . After registering, you will receive a confirmation…
Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS
Imetelstat is an oligonucleotide telomerase inhibitor recently approved by the US Food and Drug Administration for adults with lower-risk myelodysplasia wh
Preparation, Education Impact Discharge Readiness Among Patients With Stoma – Oncology Nurse Advisor
A cross-sectional survey and semistructured interviews were implemented to identify stoma patients’ and caregivers’ readiness for hospital discharge.
Volume 85 Issue 3 | Cancer Research | American Association for Cancer Research
Cancer Research | 85 | 3 | February 2025
Cancer research fuels life-saving work – The Cancer Letter
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives…
Tandem CD20-CD19-Directed CAR T-Cell Therapy for Relapsed/Refractory DLBCL: Zamtocabtagene Autoleucel
Nirav Shah, MD, discusses findings from an interim analysis of the phase 2 DALY II trial, which is the first pivotal trial evaluating tandem CD20-CD19…
Webinars
Join us for upcoming webinars associated with AACR IO: Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy
